Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The effect of L-arginine on sexual function and depression
IRCT20100127003210N26Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2022
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of arginine in female sexual dysfunction (FSD) and major depressive disorder (MDD), sponsored by Shahid Beheshti University of Medical Sciences. Started Sep 2022; status: completed.
02
Drugs
arginine
03
Conditions
female sexual dysfunction (FSD)major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20100127003210N26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100127003210N26.